Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Efficacy of the Infusion of Donor Plasma, Convalescent From SARS-CoV-2 Infection, to Patients With Recent Infection.

NCT05247307 is registered in ClinicalTrials.gov with Hospital Galdakao-Usansolo as lead sponsor.

NCT NCT05247307
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05247307 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Efficacy of the Infusion of Donor Plasma, Convalescent From SARS-CoV-2 Infection, to Patients With Recent Infection.
Lead sponsor
Hospital Galdakao-Usansolo
Phase
Phase 3
Overall status
Terminated
Start date
March 31, 2020
Completion date
December 31, 2021
Enrollment
93 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19